m6A RNA methylation facilitates pre-mRNA 3'-end formation and is essential for viability of Toxoplasma gondii.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
07 2021
Historique:
received: 25 01 2021
accepted: 16 07 2021
revised: 10 08 2021
pubmed: 30 7 2021
medline: 25 2 2023
entrez: 29 7 2021
Statut: epublish

Résumé

Toxoplasma gondii is an obligate intracellular parasite that can cause serious opportunistic disease in the immunocompromised or through congenital infection. To progress through its life cycle, Toxoplasma relies on multiple layers of gene regulation that includes an array of transcription and epigenetic factors. Over the last decade, the modification of mRNA has emerged as another important layer of gene regulation called epitranscriptomics. Here, we report that epitranscriptomics machinery exists in Toxoplasma, namely the methylation of adenosines (m6A) in mRNA transcripts. We identified novel components of the m6A methyltransferase complex and determined the distribution of m6A marks within the parasite transcriptome. m6A mapping revealed the modification to be preferentially located near the 3'-boundary of mRNAs. Knockdown of the m6A writer components METTL3 and WTAP resulted in diminished m6A marks and a complete arrest of parasite replication. Furthermore, we examined the two proteins in Toxoplasma that possess YTH domains, which bind m6A marks, and showed them to be integral members of the cleavage and polyadenylation machinery that catalyzes the 3'-end processing of pre-mRNAs. Loss of METTL3, WTAP, or YTH1 led to a defect in transcript 3'-end formation. Together, these findings establish that the m6A epitranscriptome is essential for parasite viability by contributing to the processing of mRNA 3'-ends.

Identifiants

pubmed: 34324585
doi: 10.1371/journal.ppat.1009335
pii: PPATHOGENS-D-21-00196
pmc: PMC8354455
doi:

Substances chimiques

RNA, Messenger 0
Methyltransferases EC 2.1.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009335

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI124723
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI145239
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Sci Rep. 2020 Apr 20;10(1):6590
pubmed: 32313079
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
Genome Biol. 2014;15(12):550
pubmed: 25516281
Trends Biotechnol. 2021 Jan;39(1):72-89
pubmed: 32620324
Bioinformatics. 2011 Jun 15;27(12):1653-9
pubmed: 21543442
Life Sci Alliance. 2019 May 29;2(3):
pubmed: 31142640
Epigenetics Chromatin. 2020 Aug 31;13(1):33
pubmed: 32867812
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Methods Mol Biol. 2020;2071:27-47
pubmed: 31758445
Genes Dev. 2018 Mar 1;32(5-6):415-429
pubmed: 29535189
Curr Top Microbiol Immunol. 2008;326:151-77
pubmed: 18630752
Biochim Biophys Acta Gene Regul Mech. 2019 Mar;1862(3):301-309
pubmed: 30342175
Elife. 2021 Jul 15;10:
pubmed: 34263725
Bioinformatics. 2012 Aug 15;28(16):2184-5
pubmed: 22743226
Annu Rev Microbiol. 2018 Sep 8;72:479-499
pubmed: 29932347
Nucleic Acids Res. 2012 Sep 1;40(17):e128
pubmed: 22610855
Mol Cell. 2016 Jul 21;63(2):306-317
pubmed: 27373337
Genes Dev. 2014 Oct 15;28(20):2248-60
pubmed: 25319826
BMC Genomics. 2012 Nov 20;13:641
pubmed: 23167306
J Biol Chem. 1999 Feb 19;274(8):5083-7
pubmed: 9988756
Front Med. 2018 Aug;12(4):481-489
pubmed: 30097961
J Mol Biol. 2018 Jul 20;430(15):2237-2243
pubmed: 29258817
Cell. 2013 Dec 5;155(6):1409-21
pubmed: 24269006
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Biomolecules. 2020 Jun 17;10(6):
pubmed: 32560344
Dev Cell. 2016 Jul 25;38(2):186-200
pubmed: 27396363
PLoS One. 2018 Aug 30;13(8):e0203317
pubmed: 30161237
J Food Prot. 2012 Jul;75(7):1292-302
pubmed: 22980013
Biochim Biophys Acta Gene Regul Mech. 2019 Mar;1862(3):329-342
pubmed: 30660758
Mol Cell Biol. 2001 Dec;21(24):8346-56
pubmed: 11713271
Front Microbiol. 2018 Oct 29;9:2587
pubmed: 30420849
Folia Parasitol (Praha). 2014 Dec;61(6):485-94
pubmed: 25651689
IEEE/ACM Trans Comput Biol Bioinform. 2018 Mar-Apr;15(2):526-534
pubmed: 29610101
Nucleic Acids Res. 2017 Jun 2;45(10):6051-6063
pubmed: 28334903
mBio. 2014 May 13;5(3):e01114-14
pubmed: 24825012
Nature. 2015 Oct 22;526(7574):591-4
pubmed: 26458103
Nat Commun. 2017 Mar 06;8:14574
pubmed: 28262680
mBio. 2017 May 2;8(3):
pubmed: 28465425
Front Plant Sci. 2020 Aug 14;11:1252
pubmed: 32922424
Eukaryot Cell. 2009 Apr;8(4):530-9
pubmed: 19218426
Wiley Interdiscip Rev RNA. 2019 Jul;10(4):e1529
pubmed: 30848101
New Phytol. 2017 Dec;216(4):1205-1222
pubmed: 28850721
J Biochem Mol Biol. 2004 Jul 31;37(4):474-9
pubmed: 15469736
Eukaryot Cell. 2009 Apr;8(4):520-9
pubmed: 19218423
Emerg Infect Dis. 2011 Jan;17(1):7-15
pubmed: 21192848
Nucleic Acids Res. 2003 Aug 1;31(15):4472-80
pubmed: 12888507
Nat Chem Biol. 2014 Feb;10(2):93-5
pubmed: 24316715
EMBO Mol Med. 2017 Mar;9(3):385-394
pubmed: 28148555
Mol Biochem Parasitol. 2004 Oct;137(2):229-38
pubmed: 15383293
Antisense Nucleic Acid Drug Dev. 2002 Aug;12(4):275-81
pubmed: 12238816
Cell Discov. 2018 Feb 27;4:10
pubmed: 29507755
Nat Chem Biol. 2011 Oct 16;7(12):885-7
pubmed: 22002720
mSphere. 2017 Feb 22;2(1):
pubmed: 28251183
Exp Parasitol. 1994 Jun;78(4):361-70
pubmed: 8206135
Bioinformatics. 2016 Jun 15;32(12):i378-i385
pubmed: 27307641
Mol Biochem Parasitol. 2000 Sep;110(1):43-51
pubmed: 10989144
Nature. 2012 Apr 29;485(7397):201-6
pubmed: 22575960
Biomolecules. 2015 Jun 08;5(2):1151-68
pubmed: 26061761
Cell. 2012 Jun 22;149(7):1635-46
pubmed: 22608085
Biochim Biophys Acta Gene Regul Mech. 2019 Mar;1862(3):222-229
pubmed: 30395944
Mol Plant. 2021 Apr 5;14(4):571-587
pubmed: 33515768
mBio. 2021 Apr 27;12(2):
pubmed: 33906926
Biochim Biophys Acta Gene Regul Mech. 2019 Mar;1862(3):319-328
pubmed: 30290229
Lancet. 2004 Jun 12;363(9425):1965-76
pubmed: 15194258
Biochem Biophys Res Commun. 2019 Jan 22;508(4):1286-1290
pubmed: 30573362
Plant Biotechnol J. 2019 Jul;17(7):1194-1208
pubmed: 31070865
Plant Cell. 2012 Nov;24(11):4376-88
pubmed: 23136375
Cell. 2016 Sep 8;166(6):1423-1435.e12
pubmed: 27594426
Nat Microbiol. 2019 Dec;4(12):2246-2259
pubmed: 31384004

Auteurs

Michael J Holmes (MJ)

Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.

Leah R Padgett (LR)

Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.

Matheus S Bastos (MS)

Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.

William J Sullivan (WJ)

Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Department of Microbiology & Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH